Integrity Alliance’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71M Sell
112,680
-1,348
-1% -$35.3K 0.08% 190
2026
Q1
$3.2M Buy
114,028
+430
+0.4% +$11.4K 0.12% 148
2025
Q4
$2.83M Buy
113,598
+22,457
+25% +$566K 0.1% 166
2025
Q3
$2.32M Buy
91,141
+39,127
+75% +$966K 0.11% 154
2025
Q2
$1.26M Sell
52,014
-72,813
-58% -$1.7M 0.07% 193
2025
Q1
$3.16M Buy
124,827
+73,788
+145% +$1.93M 0.13% 136
2024
Q4
$1.35M Buy
+51,039
New +$1.38M 0.15% 88

Other funds holding PFE

Integrity Alliance's PFE Position: Q2 2026 in Review

Integrity Alliance reduced its Pfizer (PFE) stake by 1.2% in Q2 2026, selling an estimated $35.3K and leaving 112,680 shares worth $2.71M. The position accounts for 0.08% of the portfolio, ranked #190.

Integrity Alliance first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.2M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Integrity Alliance held 112,680 shares of Pfizer worth $2.71M as of Q2 2026.
  • Integrity Alliance sold 1,348 Pfizer shares in Q2 2026, an estimated $35.3K.
  • Pfizer made up 0.08% of Integrity Alliance's portfolio in Q2 2026, its #190 holding.
  • Integrity Alliance first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Integrity Alliance's Pfizer position peaked at $3.2M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.